CClinicalTrials.gg
Status unknownNCT01375894Updated Jan 2, 2012

Body Movement Imitation and Perspective Perception Among Psychiatric Patients

An interventional study of imitation assessment using the 5-dt "data glove". in Schizophrenia and Depression, sponsored by Shalvata Mental Health Center. Status unknown at 1 site in Israel. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2012-01-02.

Sponsored by Shalvata Mental Health Center · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Dec 2011), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
20 Years to 65 Years
Sex
All
01

Study summary

The ability to understand the other's perspective and respond accordingly is the most important normal process of daily social life and is probably one of the foundations of human existence. This capability is reflected, inter alia, as an imitation - an important and effective form of learning which is very developed in humans. When we are required to imitate a particular movement, speed of response depends on the perspective of the movement. Imitative response is implemented faster when the movement is observed from first-person perspective, than if the motion is presented from the perspective of a third party.

While healthy individuals don't find it difficult to imitate, or to understand the other's emotion expression, there are psychiatric populations (such as autism and schizophrenia) who find it difficult to demonstrate these capabilities (Park, Matthews et al. 2008). Beyond these capabilities impairment, schizophrenic patients have difficulty distinguishing between their arm movements and those of a foreign hand and find it difficult to leave the boundaries of egocentric interpretation of reality and adopt the other's point of view. These behavioral disorders arise from defects in the network of mirror neurons (Buccino and Amore 2008; Langdon, Coltheart et al. 2010).

Therefore, the investigator expect that schizophrenic patients will not see a preference for movements that will be displayed in first-person perspective from the same movements that will be displayed from the perspective of a third party. Consequently, the investigator speculate that these subjects will not exhibit differences at imitating the response of which will be presented from different perspectives (Jackson, Meltzoff et (al. 2006.

02

Conditions studied

  • Schizophrenia
  • Depression

Browse trials for

03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's planned enrollment of 60 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Shalvata Mental Health Center is the lead sponsor of 73 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Men and women aged 20-65.
  2. Subjects who met the criteria for diagnosis of major DSM-IV for schizophrenia or unipolar depression.
  3. Subjects with normal or corrected vision.
  4. Subjects who sign informed consent for their participation in the experiment

Exclusion criteria

Exclusion Criteria:

  1. Patients with acute disorder, or an unstable patient. Especially neurological disorders or head injuries.
  2. Drug Abuse in the past year.
  3. Lack of jurisdiction, such as people with mental retardation or dementia.
  4. assessed with high suicide risk.
  5. patients which are Compulsory hospitalized.
  6. Pregnant women
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    depresive patients

    30 patients suffering from depression

    Device: imitation assessment using the 5-dt "data glove".

  • Experimental
    Schizophrenia patients

    30 Schizophrenia patients

    Device: imitation assessment using the 5-dt "data glove".

Interventions

  • Deviceimitation assessment using the 5-dt "data glove".

    measuring the speed of the hand during imitation

06

What researchers measure

Primary outcomes

  1. speed of hand movement according to the reaction glove

    Time frame: 30 minutes

07

Study locations

1 site
  • Shalvata MHC
    Hod hasharon, Israel
    • Hilik Levkovitz, prof. · Contact · ylevk@clalit.org.il · 09-7478644
    • Hilik Levkovitz, prof. · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01375894
Lead sponsor
Shalvata Mental Health Center
Responsible party
Sponsor
First posted
Jun 17, 2011
Start date
Mar 2012
Primary completion
Dec 2012 (estimated)
Completion
Dec 2012 (estimated)
Last update
Jan 2, 2012

Study contacts

Hilik Levkovitz, prof.
Contact
ylevk@clalit.org.il
09-7478644

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion